Kevin Nguyen, PharmD, BCIDP

home / authors / kevin-nguyen-pharmd

Nguyen is a clinical specialist, Infectious Disease, and associate director of Antimicrobial Stewardship at St. Christopher's Hospital for Children in Philadelphia.

Articles

A Tale of 2 Settings: How Outpatient Clinics Differ From Institutions in Delivering Stewardship

A Tale of 2 Settings: How Outpatient Clinics Differ From Institutions in Delivering Stewardship

John Parkinson;Kevin Nguyen, PharmD, BCIDP
September 11th 2024

Kevin Nguyen, PharmD, offers some insights on some of the challenges in the outpatient setting with regards to stewardship, and novel strategies being utilized.

Read More

Discussing Outpatient COVID-19 Treatments

Discussing Outpatient COVID-19 Treatments

Neelesh Agarwal, PharmD;Kevin Nguyen, PharmD, BCIDP;Seung Ha, PharmD
December 10th 2021

Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
COVID-19 Therapy Roundtable: Addressing Inpatient Clinical Care
Published: December 12th 2024 | Updated: December 25th 2024
COVID-19 Therapy Roundtable: Addressing Inpatient Clinical Care
CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas
Published: December 20th 2024 | Updated: December 25th 2024
CACTUS Study Compares Ceftolozane-Tazobactam vs. Ceftazidime-Avibactam for MDR Pseudomonas
The First Severe Case of Avian Influenza Confirmed in the United States
Published: December 19th 2024 | Updated: December 25th 2024
The First Severe Case of Avian Influenza Confirmed in the United States
COVID-19 Roundtable: Should Clinicians Consider Off Label COVID Therapies?
Published: December 19th 2024 | Updated: December 25th 2024
COVID-19 Roundtable: Should Clinicians Consider Off Label COVID Therapies?
Effects of Switching Antibiotics Mid-Treatment on Antimicrobial Resistance
Published: March 9th 2022 | Updated: December 25th 2024
Effects of Switching Antibiotics Mid-Treatment on Antimicrobial Resistance
© 2024 MJH Life Sciences

All rights reserved.